| Dr Peter F Orio Iii, DO | |
|
75 Francis St, Boston, MA 02115-6110 | |
| (617) 732-5500 | |
| Not Available |
| Full Name | Dr Peter F Orio Iii |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 23 Years |
| Location | 75 Francis St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174639736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | OP00001834 (Washington) | Secondary |
| 2085R0001X | Radiology - Radiation Oncology | 245223 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Milford Regional Medical Center | Milford, MA | Hospital |
| South Shore Hospital | South weymouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
Fox Business reports on what it sees as the five major health law elements in the pipeline this year. Meanwhile, other coverage focuses on the final round of health plan waivers issued by the Centers for Medicare and Medicaid Services, more about accountable care organizations, explanations of why private exchanges might catch on and details of the health law's contraception policies.
More than one in three tumors that affect the central nervous system are meningiomas and most are benign.
The implications of caring for aging Americans continues to worry many as news outlets examine workforce and cost issues related to treating older Americans.
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.
› Verified 8 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
Fox Business reports on what it sees as the five major health law elements in the pipeline this year. Meanwhile, other coverage focuses on the final round of health plan waivers issued by the Centers for Medicare and Medicaid Services, more about accountable care organizations, explanations of why private exchanges might catch on and details of the health law's contraception policies.
More than one in three tumors that affect the central nervous system are meningiomas and most are benign.
The implications of caring for aging Americans continues to worry many as news outlets examine workforce and cost issues related to treating older Americans.
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.
› Verified 8 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427076967 PECOS PAC ID: 3870405988 Enrollment ID: O20040322001122 |
News Archive
Fox Business reports on what it sees as the five major health law elements in the pipeline this year. Meanwhile, other coverage focuses on the final round of health plan waivers issued by the Centers for Medicare and Medicaid Services, more about accountable care organizations, explanations of why private exchanges might catch on and details of the health law's contraception policies.
More than one in three tumors that affect the central nervous system are meningiomas and most are benign.
The implications of caring for aging Americans continues to worry many as news outlets examine workforce and cost issues related to treating older Americans.
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.
› Verified 8 days ago
| Entity Name | Radiation Therapy Of Southeastern Mass, Llc |
|---|---|
| Entity Type | Part B Supplier - Radiation Therapy Center |
| Entity Identifiers | NPI Number: 1104978519 PECOS PAC ID: 9335248343 Enrollment ID: O20070615000252 |
News Archive
Fox Business reports on what it sees as the five major health law elements in the pipeline this year. Meanwhile, other coverage focuses on the final round of health plan waivers issued by the Centers for Medicare and Medicaid Services, more about accountable care organizations, explanations of why private exchanges might catch on and details of the health law's contraception policies.
More than one in three tumors that affect the central nervous system are meningiomas and most are benign.
The implications of caring for aging Americans continues to worry many as news outlets examine workforce and cost issues related to treating older Americans.
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.
› Verified 8 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Fox Business reports on what it sees as the five major health law elements in the pipeline this year. Meanwhile, other coverage focuses on the final round of health plan waivers issued by the Centers for Medicare and Medicaid Services, more about accountable care organizations, explanations of why private exchanges might catch on and details of the health law's contraception policies.
More than one in three tumors that affect the central nervous system are meningiomas and most are benign.
The implications of caring for aging Americans continues to worry many as news outlets examine workforce and cost issues related to treating older Americans.
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter F Orio Iii, DO 75 Francis St, Boston, MA 02115-6110 Ph: () - | Dr Peter F Orio Iii, DO 75 Francis St, Boston, MA 02115-6110 Ph: (617) 732-5500 |
News Archive
Fox Business reports on what it sees as the five major health law elements in the pipeline this year. Meanwhile, other coverage focuses on the final round of health plan waivers issued by the Centers for Medicare and Medicaid Services, more about accountable care organizations, explanations of why private exchanges might catch on and details of the health law's contraception policies.
More than one in three tumors that affect the central nervous system are meningiomas and most are benign.
The implications of caring for aging Americans continues to worry many as news outlets examine workforce and cost issues related to treating older Americans.
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure.
› Verified 8 days ago
Jennifer Michelle Thomas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Department Of Radiology, Boston, MA 02115 Phone: 617-732-6248 | |
Dr. Meghavi Mashar, MB BCHIR Radiology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 | |
Rafeeque A Bhadelia, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Bidmc Wcc90, Boston, MA 02215 Phone: 617-754-2058 Fax: 617-754-2004 | |
Dr. Srinivasan Mukundan Jr., M.D. Radiology Medicare: Medicare Enrolled Practice Location: 75 Francis St, Brigham And Women's Hospital, Boston, MA 02115 Phone: 617-732-7260 | |
Raymond W Liu, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Grb 293, Boston, MA 02114 Phone: 917-923-2079 | |
Dr. Hillary R. Kelly, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Grb-273a, Boston, MA 02114 Phone: 617-726-8320 Fax: 617-724-3338 | |
Dr. Tina Young Poussaint, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6450 |